Resection of the Splenic Vessels during Laparoscopic Central Pancreatectomy is Safe and Does Not Compromise Preservation of the Distal Pancreatectomy

Objective: Low potential malignant diseases are more frequently discovered and laparoscopic central pancreatectomy (LCP) can be indicated. LCP usually preserving splenic vessels (LCP-PreSV), allows a low-risk of diabetes at the expense high morbidity represented mainly by postoperative pancreatic fistula (POPF) haemorrhage (PPH). We evaluated impact resection (LCP-ResSV) on short long-term complications. Methods: This was retrospective single center cohort study. Between 2008 to 2020, 84 were performed, including 15 LCP-ResSV 69 LCP-PreSV. The matched [1:2] compared with 30 LCP-PreSV according age, sex, BMI, tumour characteristics. Results: In group, size larger (40 vs 21 mm;p = 0.008) right transection performed body (53% 13%;p=0.01). There no difference regarding characteristics (Wirsung duct consistency). median operative time (min) longer (210 180; p=0.15) blood loss (100 mL 50 mL; p=0.012), respectively. differences mortality (0% 3%; p 0.47), grade B-C POPF (27% 27%; 1), re-intervention (7% 13%; 0.50), PPH 0.13), hospital stay (20 days 22 days; 0.15) new onset 10%; 0.67). Conclusion: is safe technical modification CP or endocrine insufficiency, LCP-PresSV. Furthermore, it could reduce risk PPH.